✦ LIBER ✦

Different haemodynamic effects of glimepiride in healthy and diabetic rabbits

✍ Scribed by Zoltán Aranyi; Zsófia M. Koltai; Erzsébet Kékessi; György Ballagi-Pordány; Gábor Pogátsa

Book ID: 115983097
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 81 KB
Volume: 23
Category: Article
ISSN: 0022-2828
DOI: 10.1016/0022-2828(91)90794-m

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Haemodynamic and renal effects of urodil

Haemodynamic and renal effects of urodilatin in healthy volunteers

✍ M. KENTSCH; D. LUDWIG; C. DRUMMER; R. GERZER; G. MÜLLER-ESCH 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 578 KB

Haemodynamic effects of diltiazem in hea

Haemodynamic effects of diltiazem in healthy volunteers [letter]

✍ H Valette; E Apoil 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB

Effects of glimepiride on in vivo insuli

Effects of glimepiride on in vivo insulin action in normal and diabetic rats

✍ Juichi Sato; Isao Ohsawa; Yoshiharu Oshida; Yuzo Sato; Nobuo Sakamoto 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 642 KB

Effects of propofol on ultrasonic indica

Effects of propofol on ultrasonic indicators of haemodynamic function in rabbits

✍ Christine Baumgartner; Melanie Bollerhey; Julia Henke; Silvia Wagner; Martin Ung 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

Effects of glimepiride and glibenclamide

Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients

✍ Naoto Katakami; Hideaki Kaneto; Munehide Matsuhisa; Iichiro Shimomura; Yoshimits 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 116 KB

The haemodynamic effects and pharmacokin

The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteers

✍ D. L. Wolf; J. J. Ferry; A. E. Hearron; M. O. Froeschke; J. R. Luderer 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 653 KB

We have studied the effects of intravenous nicorandil, a mixed arterial and venous vasodilator, in 48 healthy volunteers. Nicorandil (20, 28, 39, 54, 74, 103, 144, or 200 micrograms.kg-1) or placebo were given over 5 min to subjects supine (16 subjects, 2 doses) or sitting (32 subjects, 1 dose) in a